July 21 (Reuters) - Momenta Pharmaceuticals Inc:
Advertisement
* Momenta Pharmaceuticals announces jury verdict in Enoxaparin Sodium Injection patent litigation against Amphastar
* U.S. court issued verdict finding that co's U.S. patent covering methods for manufacturing of generic LOVENOX "was infringed" Source text for Eikon: Further company coverage: